{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T21:30:07Z","timestamp":1787261407146,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd003546.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T00:00:00Z","timestamp":1352851200000}}],"reference-count":125,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003546.pub3","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T19:26:57Z","timestamp":1352402817000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Management of sexual dysfunction due to antipsychotic drug therapy"],"prefix":"10.1002","volume":"2012","author":[{"given":"Hannah M","family":"Schmidt","sequence":"first","affiliation":[{"name":"University Medical Center Freiburg; Department of Psychiatry and Psychotherapy; Hauptstrasse 5 Freiburg im Breisgau Germany D-79104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Hagen","sequence":"additional","affiliation":[{"name":"University Medical Center Freiburg; Department of Psychiatry and Psychotherapy; Hauptstrasse 5 Freiburg im Bresigau Baden-W\u00fcrttemberg Germany D-79104"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levente","family":"Kriston","sequence":"additional","affiliation":[{"name":"University Medical Center, Hamburg - Eppendorf; Department of Medical Psychology; Martinistrasse 52 Hamburg Germany 20246"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Soares-Weiser","sequence":"additional","affiliation":[{"name":"Enhance Reviews Ltd; Central Office, Cobweb Buildings The Lane, Lyford Wantage UK OX12 0EE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Maayan","sequence":"additional","affiliation":[{"name":"Enhance Reviews Ltd; Central Office, Cobweb Buildings The Lane, Lyford Wantage UK OX12 0EE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M","family":"Berner","sequence":"additional","affiliation":[{"name":"Rhein-Jura Klinik; Department of Psychiatry and Psychotherapy; Schneckenhalde 13 Bad S\u00e4ckingen Germany D-79713"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,11,14]]},"reference":[{"key":"10.1002\/14651858.CD003546.pub3-BIB0001|cit1","unstructured":"Byerly M J Nakonezny P Bugno R Boles J A randomized, double-blind pilot trial of switching to quetiapine vs. risperidone continuation in outpatients with risperidone-associated sexual dysfunction Proceedings of the 159th Annual Meeting of the American Psychiatric Association; 2006 May 20-25; Toronto, Canada 2006"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0003|cit2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3371\/CSRP.3.4.3","article-title":"A pilot study to determine a prolactin threshold that identifies improved sexual functioning when switching from a prolactin-elevating to a prolactin-neutral antipsychotic","volume":"3","author":"Byerly","year":"2010","journal-title":"Clinical Schizophrenia and Related Psychoses"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0002|cit3","doi-asserted-by":"crossref","unstructured":"Byerly MJ Nakonezny PA Rush AJ Sexual functioning associated with quetiapine switch vs risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial Psychiatry Research 2008 115 20","DOI":"10.1016\/j.psychres.2007.02.014"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/00926230701267829","article-title":"The relationship between serum prolactin level and sexual functioning among male outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind trial of risperidone vs quetiapine","volume":"33","author":"Nakonezny","year":"2007","journal-title":"Journal of Sex and Marital Therapy"},{"issue":"3","key":"10.1002\/14651858.CD003546.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1176\/appi.ajp.163.3.494","article-title":"Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial","volume":"163","author":"Gopalakrishnan","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.psyneuen.2005.12.006","article-title":"Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine","volume":"31","author":"Kinon","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0007|cit7","unstructured":"Kinon BJ Liu H Ahl J Sexual dysfunction associated with neuroleptic-induced hyperprolactinemia improves with reduction in prolactin levels Proceedings of the 156th Annual Meeting of the American Psychiatric Association; 2003 May 17-22; San Francisco, California, USA 2003"},{"issue":"4","key":"10.1002\/14651858.CD003546.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00002826-200307000-00008","article-title":"Selegiline in the treatment of sexual dysfunction in schizophrenic patinets maintained on neuroleptics: a pilot study","volume":"26","author":"Kodesh","year":"2003","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0009|cit9","first-page":"137","article-title":"Sexual dysfunction in male schizophrenic patients","volume":"56","author":"Aizenberg","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD003546.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/00926239608414660","article-title":"Low-dose imipramine for thioridazine-induced male orgasmic disorder","volume":"22","author":"Aizenberg","year":"1996","journal-title":"Journal of Sex & Marital Therapy"},{"issue":"6","key":"10.1002\/14651858.CD003546.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/sj.ijir.3900906","article-title":"Sildenafil use in patients with olanzapine-induced erectile dysfunction","volume":"14","author":"Atmaca","year":"2002","journal-title":"International Journal of Impotence Research"},{"issue":"1","key":"10.1002\/14651858.CD003546.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4088\/JCP.v65n0117","article-title":"An open-label trial of sildenafil addition in risperidone-treated male schizophrenia patients with erectile dysfunction","volume":"65","author":"Aviv","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"issue":"A","key":"10.1002\/14651858.CD003546.pub3-BIB0013|cit13","first-page":"31","article-title":"High doses of clorotepin in chronic schizophrenia (preliminary report)","volume":"21","author":"Bastecky","year":"1980","journal-title":"Agressologie"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0924-9338(99)00154-6","article-title":"Sildenafil citrate (Viagra) treatment of sexual dysfunction in a schizophrenic patient","volume":"14","author":"Benatov","year":"1999","journal-title":"European Psychiatry"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0015|cit15","first-page":"421","article-title":"Changes in prolactin levels and arizona sexual experience scale (ASEX) scores among patients switched from risperidone to aripiprazole in the schizophrenia trial of aripiprazole (STAR) study","volume":"33","author":"Beuzen","year":"2007","journal-title":"Schizophrenia Bulletin"},{"issue":"1","key":"10.1002\/14651858.CD003546.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00004714-199602000-00007","article-title":"Antipsychotic and anxiolytic properties of risperidone, haloperidol and methotrimeprazine in schizophrenic patients","volume":"16","author":"Blin","year":"1996","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0017|cit17","first-page":"14","article-title":"Risperidone versus quetiapine: preliminary results of a comparative study on sexual dysfunctioning and prolactin elevation","volume":"2","author":"Bruggeman","year":"2002","journal-title":"Nordic Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003546.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/00926230490465082","article-title":"An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction","volume":"30","author":"Byerly","year":"2004","journal-title":"Journal of Sex & Marital Therapy"},{"issue":"6","key":"10.1002\/14651858.CD003546.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00004714-198712000-00002","article-title":"The risks and benefits of clozapine versus chlorpromazine","volume":"7","author":"Claghorn","year":"1987","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003546.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00004714-198704000-00008","article-title":"Amantadine in the treatment of neuroendocrine side effects of neuroleptics","volume":"7","author":"Correa","year":"1987","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003546.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/0269881107066333","article-title":"A naturalistic, 9-month follow-up, comparing olanzapine and conventional antipsychotics on sexual function and hormonal profile for males with schizophrenia","volume":"21","author":"Costa","year":"2007","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD003546.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1005425728062","article-title":"Clozapine vs. haloperidol: antipsychotic effects on sexual function in schizophrenia","volume":"18","author":"Covington","year":"2000","journal-title":"Sexuality and Disability"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/JCP.0b013e318222bb29","article-title":"A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (ras study)","volume":"31","author":"Boer","year":"2011","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"9","key":"10.1002\/14651858.CD003546.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0033-3182(82)73071-3","article-title":"Sexual dysfunction in women using major tranquilizers","volume":"23","author":"Degen","year":"1982","journal-title":"Psychosomatics"},{"issue":"259","key":"10.1002\/14651858.CD003546.pub3-BIB0025|cit25","first-page":"266","article-title":"Bupropion and thiothixene versus placebo and thiothixene in the treatment of depression in schizophrenia","volume":"12","author":"Dufresene","year":"1988","journal-title":"Drug Development Research"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-244X-8-95","article-title":"The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913)","volume":"8","author":"Hanssens","year":"2008","journal-title":"BMC Psychiatry"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1600-0447.1993.tb03480.x","article-title":"Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbation","volume":"88","author":"Hoyberg","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0028|cit28","first-page":"2077","article-title":"Effects of olanzapine, risperidone and chlorpromazine on prolactin and erectile function in male patients with schizophrenia","volume":"24","author":"Huang","year":"2008","journal-title":"Modern Medicine and Health [\u73b0\u4ee3\u533b\u836f\u536b\u751f]"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1345\/aph.1Z432","article-title":"Effects of risperidone on gonadal axis hormones in schizophrenia","volume":"35","author":"Kaneda","year":"2001","journal-title":"Annals of Pharmacotherapy"},{"issue":"5","key":"10.1002\/14651858.CD003546.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s100720200047","article-title":"Switch to quetiapine in antipsychotic agent-related hyperprolactinemia","volume":"23","author":"Keller","year":"2002","journal-title":"Neurological Sciences"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0031|cit31","doi-asserted-by":"crossref","unstructured":"Kelly DL Conley RR A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia Psychoneuroendocrinology 2006 340 6","DOI":"10.1016\/j.psyneuen.2005.08.010"},{"issue":"5","key":"10.1002\/14651858.CD003546.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4088\/JCP.v63n0506","article-title":"Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone","volume":"63","author":"Kim","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003546.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00004714-199902000-00011","article-title":"Prolactin-levels and adverse events in patients treated with risperidone","volume":"19","author":"Kleinberg","year":"1999","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0034|cit34","unstructured":"Knegtering R Boks M Wiersma D Blijd C Bruggeman R Oer RBV Sexual dysfunctions in patients on antipsychotics Proceedings of the 155th Annual Meeting of the American Psychiatric Association; 2002 May 18-23; Philadelphia, Pennsylvania, USA 2002"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0035|cit35","unstructured":"Knegtering R Boks M Wiersma D Blijd C Bruggeman R Van Oer RB Sexual dysfunctions in patients on antipsychotics Proceedings of the 153rd Annual Meeting of the American Psychiatric Association; 2000 May 13-18; Chicago, Illinois, USA 2000"},{"issue":"1","key":"10.1002\/14651858.CD003546.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/01.jcp.0000106220.36344.04","article-title":"A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning","volume":"24","author":"Knegtering","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0037|cit37","doi-asserted-by":"crossref","unstructured":"Knegtering R Castelein S Bous H Van der Linde J Bruggeman R Kluiter H A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning Proceedings of the Bi-annual Winter Workshop on Schizophrenia Research; 2002 Feb 24 - Mar 1; Davos, Switzerland 2002","DOI":"10.1097\/01.jcp.0000106220.36344.04"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD003546.pub3-BIB0038|cit38","first-page":"163","article-title":"Sexual dysfunctions and serum prolactin levels in patients using risperidone or quetiapine: a randomised trial","volume":"53","author":"Knegtering","year":"2002","journal-title":"Schizophrenia Research"},{"issue":"4","key":"10.1002\/14651858.CD003546.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/00926230600666378","article-title":"A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning","volume":"32","author":"Knegtering","year":"2006","journal-title":"Journal of Sex and Marital Therapy"},{"issue":"1","key":"10.1002\/14651858.CD003546.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0010-440X(96)90052-8","article-title":"Sexual disorders in nonacute psychiatric outpatients","volume":"37","author":"Kockott","year":"1996","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0041|cit41","first-page":"81","article-title":"Sexual disinhibition and antipsychotics","volume":"6","author":"Kubacki","year":"1984","journal-title":"Nova Scotia Medical Bulletin"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0042|cit42","unstructured":"Mahmoud A Hayhurst KP Drake RJ Lewis SW Second generation antipsychotics improve sexual dysfunction in schizophrenia: A randomised controlled trial Schizophrenia Research and Treatment"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0043|cit43","unstructured":"Mahmoud A Hayhurst KP Lewis SW Antipsychotic drugs and sexual dysfunctions Proceedings of the 8th World Congress of Psychiatry; 2005 Sep 10-15; Cairo, Egypt 2005"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0044|cit44","first-page":"189","article-title":"Antipsychotic drugs and sexual function","volume":"67","author":"Mahmoud","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/JCP.0b013e3182199bcc","article-title":"Sexual dysfunction in first-episode schizophrenia patients results from european first episode schizophrenia trial","volume":"31","author":"Malik","year":"2011","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD003546.pub3-BIB0046|cit46","first-page":"639","article-title":"Effects of bromocriptine on neuroleptic-induced amenorrhea, galactorrhea and impotence","volume":"40","author":"Matsuoka","year":"1986","journal-title":"Japanese Journal of Psychiatry and Neurology"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1600-0447.1988.tb06300.x","article-title":"A double-blind comparative study of remoxipride and thioridazine in the acute phase of schizophrenia","volume":"78","author":"McCreadie","year":"1988","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0048|cit48","unstructured":"Mir A Shivakumar K Mcallister V O Keane V Mccrone P Aitchinson KJ Change in sexual dysfunction on switching to aripiprazole Proceedings of the 13th Biennial Winter Workshop on Schizophrenia Research; 2006 Feb 4-10; Davos, Switzerland 2006"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/0269881107082901","article-title":"Change in sexual dysfunction with aripiprazole: A switching or add-on study","volume":"22","author":"Mir","year":"2008","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0920-9964(00)00061-X","article-title":"Frequency of sexual dysfunctions in patients with schizophrenia on haloperidol, clozapine or risperidone","volume":"48","author":"Mullen","year":"2001","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0051|cit51","unstructured":"Rosenberg K P Bleiberg K Kocsis J H Psychotropic-induced sexual dysfunction among outpatients Proceedings of the 154th Annual Meeting of the American Psychiatric Association; 2001 May 5-10; New Orleans, Louisiana, USA 2001"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0052|cit52","unstructured":"Rosenberg KP Bleiberg K Kocsis JH Psychotropic-induced sexual dysfunction among outpatients Proceedings of the 155th Annual Meeting of the American Psychiatric Association; 2002 May 18-23; Philadelphia, Pennsylvania, USA Philadelphia, Pennsylvania, USA 2002"},{"issue":"6","key":"10.1002\/14651858.CD003546.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0893-133X(02)00375-5","article-title":"Amisulpride versus risperidone in chronic schizophrenia: results of a 6-month double-blind study","volume":"27","author":"Sechter","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/00926239908404002","article-title":"Two additional uses for sildenafil in psychiatric patients","volume":"25","author":"Segraves","year":"1999","journal-title":"Journal of Sex & Marital Therapy"},{"issue":"5","key":"10.1002\/14651858.CD003546.pub3-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0163-8343(00)00097-9","article-title":"Haloperidol-induced impotence improved by switching to olanzapine","volume":"22","author":"Tsai","year":"2000","journal-title":"General Hospital Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD003546.pub3-BIB0056|cit56","first-page":"355","article-title":"Effect of amantadine on sexual dysfunction in neuroleptic-treated male schizophrenic patients","volume":"21","author":"Valevski","year":"1998","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0924-9338(96)84784-5","article-title":"A survey of psychosexual arousability in male patients on depot neuroleptic medication","volume":"11","author":"Wesby","year":"1996","journal-title":"European Psychiatry"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0058|cit58","unstructured":"Wirshing DA Perkins V Marder SR Wirshing WC Sexual side effects of atypical antipsychotic medications Proceedings of the 152nd Annual Meeting of the American Psychiatric Association; 1999 May 15-20; Washington DC, USA 1999"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0059|cit59","first-page":"247","article-title":"Sexual dysfunction of 220 schizophrenics","volume":"10","author":"Zhang","year":"2002","journal-title":"Health Psychology Journal"},{"issue":"2","key":"10.1002\/14651858.CD003546.pub3-BIB0060|cit60","first-page":"132","article-title":"Hydrogen benzene that clozapine induced salivation Immunotherapy Clinical [Google Translate]","volume":"19","author":"\u5468\u4e91","year":"2009","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34\u5e8a\u7cbe\u795e\u533b\u5b66\u6742\u5fd7]"},{"issue":"9","key":"10.1002\/14651858.CD003546.pub3-BIB0061|cit61","first-page":"1117","article-title":"A pilot study on the sexual hormones level of male patients with schizophrenia","volume":"25","author":"\u5f20\u4e1c\u536b","year":"2008","journal-title":"\u5b9e\u7528\u533b\u836f\u6742\u5fd7"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0062|cit62","unstructured":"\u8096\u6500\u6500 \u6797\u4f1f\u6210 \u5b8b\u5b81 \u9ad8\u9547\u677e Effect of quetiapine on PRL secretion and sexual function of male schizophrenic patients Chinese Journal of Health Psychology [\u4e2d\u56fd\u5065\u5eb7\u5fc3\u7406\u5b66\u6742\u5fd7] 2009 897 9"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0063|cit63","unstructured":"\u8c22\u65b0\u5e74 \u8212\u4eba\u4e5d \u94a6\u6843\u6843 Aripiprazole and risperidone in the treatment of male schizophrenia efficacy and sexual function [Google translate] Hunan Medical Journal 2008 1111 3"},{"issue":"18","key":"10.1002\/14651858.CD003546.pub3-BIB0064|cit64","first-page":"2883","article-title":"Aripiprazole on male sexual function in patients with schizophrenia study Google Translate","volume":"31","author":"\u9773\u897f\u9f99","year":"2010","journal-title":"Journal of Qiqihar Medical College [Qiqihar Yixueyuan xuebao]"},{"issue":"13","key":"10.1002\/14651858.CD003546.pub3-BIB0065|cit65","first-page":"20","article-title":"Quetiapine and risperidone on sex hormone levels in patients with schizophrenia Google Translate","volume":"19","author":"\u9ec4\u7cb1\u9554","year":"2010","journal-title":"China Pharmaceuticals"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00002826-199706000-00004","article-title":"Mianserin, a 5-HT2a\/c and alpha2 antagonist in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors","volume":"30","author":"Aizenberg","year":"1997","journal-title":"Clinical Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD003546.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1743-6109.2005.00145.x","article-title":"Psychological and interpersonal dimensions of sexual function and dysfunction","volume":"2","author":"Althof","year":"2005","journal-title":"Journal of Sexual Medicine"},{"issue":"7066","key":"10.1002\/14651858.CD003546.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD003546.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14681994.2011.567259","article-title":"Drug-induced sexual dysfunction and mental health patients' attitude to psychotropic medications","volume":"26","author":"Apantaku-Olajide","year":"2011","journal-title":"Sexual & Relationship Therapy"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD003546.pub3-BIB0072|cit72","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"issue":"22","key":"10.1002\/14651858.CD003546.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM198312013092204","article-title":"Bias in treatment assignment in controlled clinical trials","volume":"309","author":"Chalmers","year":"1983","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003546.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00002018-199819040-00005","article-title":"Psychotropic drug-induced sexual dysfunction","volume":"19","author":"Clayton","year":"1998","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2005.12.007","article-title":"Burden of phase-specific sexual dysfunction with SSRIs","volume":"91","author":"Clayton","year":"2006","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/sim.1205","article-title":"Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes","volume":"21","author":"Curtin","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/sim.1206","article-title":"Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes","volume":"21","author":"Curtin","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0078|cit78","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town Cape Town The Cochrane Collaboration 2000"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0081|cit81","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0083|cit83","doi-asserted-by":"crossref","unstructured":"El Kissi Y Mannai J Laroussi M Gaabout S Ayachi M Hadj Ali B P03-209 - Sexual function in untreated then treated schizophrenic patients: a prospective study European Psychiatry 2011 1378","DOI":"10.1016\/S0924-9338(11)73083-8"},{"issue":"1","key":"10.1002\/14651858.CD003546.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini mental state: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatry Research"},{"issue":"7","key":"10.1002\/14651858.CD003546.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0087|cit87","first-page":"406","article-title":"Psychotropic medications and their effect on sexual function: diagnosis, biology and treatment approaches","volume":"55","author":"Gitlin","year":"1994","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJM199805143382001","article-title":"Oral sildenafil in the treatment of erectile dysfunction","volume":"338","author":"Goldstein","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the health survey for england 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0090|cit90","volume-title":"Early Clinical Drug Evaluation (ECDEU) Assessment Manual for Psychopharmacology","author":"Guy","year":"1976"},{"issue":"5","key":"10.1002\/14651858.CD003546.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1440-1819.2012.02376.x","article-title":"Effects of antipsychotic polypharmacy on side-effects and concurrent use of medications in schizophrenic outpatients","volume":"66","author":"Hashimoto","year":"2012","journal-title":"Psychiatry & Clinical Neurosciences"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0092|cit92","first-page":"25","article-title":"Fluoxetine-induced sexual dysfunction","volume":"51","author":"Herman","year":"1990","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0094|cit94","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","volume":"2","author":"Higgins","year":"2005"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0095|cit95","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0096|cit96","volume-title":"The ICD-10 Classification of Mental and Behavioural Disorders","author":"World Health Organization","year":"1992"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0097|cit97","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD003546.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/oxfordjournals.schbul.a007130","article-title":"Sexuality and schizophrenia: a review","volume":"30","author":"Kelly","year":"2004","journal-title":"Schizophrenia bulletin"},{"issue":"6","key":"10.1002\/14651858.CD003546.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/jama.281.6.537","article-title":"Sexual dysfunction in the United States: prevalence and predictors","volume":"281","author":"Laumann","year":"1999","journal-title":"JAMA"},{"issue":"2-3","key":"10.1002\/14651858.CD003546.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003546.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/schbul\/sbl025","article-title":"Is the superior efficacy of new generation antipsychotics an artifact of LOCF?","volume":"33","author":"Leucht","year":"2007","journal-title":"Schizophrenia Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD003546.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/YCO.0b013e328017f6c4","article-title":"Sexual dysfunction in schizophrenia","volume":"20","author":"Malik","year":"2007","journal-title":"Current Opinion in Psychiatry"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/009262300278623","article-title":"The Arizona Sexual Experience Scale (ASEX): reliability and validity","volume":"26","author":"McGahuey","year":"2000","journal-title":"Journal of Sex and Marital Therapy"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/009262301750257146","article-title":"Changes in sexual function during acute and six-month fluoxetine therapy: a prospective assessment","volume":"27","author":"Michelson","year":"2001","journal-title":"Journal of Sex and Marital Therapy"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"10","key":"10.1002\/14651858.CD003546.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1111\/j.1743-6109.2010.01709.x","article-title":"Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics","volume":"7","author":"Montejo","year":"2010","journal-title":"Journal of Sexual Medicine"},{"issue":"10","key":"10.1002\/14651858.CD003546.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7748\/mhp2012.07.15.10.20.c9196","article-title":"Sexual dysfunction in people with schizophrenia","volume":"15","author":"Nicolaou","year":"2012","journal-title":"Mental Health Practice"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"issue":"1","key":"10.1002\/14651858.CD003546.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"78","DOI":"10.7326\/0003-4819-116-1-78","article-title":"A consumer's guide to subgroup analyses","volume":"116","author":"Oxman","year":"1992","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003546.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schultz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/9780470712184.ch12","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2008"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD003546.pub3-BIB0115|cit115","first-page":"48","article-title":"Antidepressant-induced sexual dysfunction","volume":"59","author":"Segraves","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl","key":"10.1002\/14651858.CD003546.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0117|cit117","first-page":"1227","article-title":"Erectile dysfunction","volume":"15","author":"Tharyan","year":"2006","journal-title":"BMJ Clinical Evidence"},{"issue":"5","key":"10.1002\/14651858.CD003546.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organistation-based intervention in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"204","DOI":"10.4088\/JCP.v67n0205","article-title":"Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey","volume":"67","author":"Williams","year":"2006","journal-title":"Jounral of Clinical Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD003546.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0121|cit121","doi-asserted-by":"crossref","unstructured":"Xiang YT Wang CY Si TM Lee EHM He YL Ungvari GS The low frequency of reported sexual dysfunction in Asian patients with schizophrenia (2001-2009): low occurrence or ignored side effect? Human Psychopharmacology 2011 352 7","DOI":"10.1002\/hup.1213"},{"key":"10.1002\/14651858.CD003546.pub3-BIB0122|cit122","doi-asserted-by":"crossref","unstructured":"Zemishlany Z AS01-02 - The impact of psychiatric disorders on sexual dysfunction: an update European Psychiatry 2012 1 1","DOI":"10.1016\/S0924-9338(12)73952-4"},{"issue":"5","key":"10.1002\/14651858.CD003546.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.eurpsy.2007.01.001","article-title":"Sexual dysfunction in patients with schizophrenia on antipsychotic medication","volume":"22","author":"\u00dc\u00e7ok","year":"2007","journal-title":"European Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD003546.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.4088\/JCP.v67n1024a","article-title":"A systematic review of research on strategies for the management of antipsychotic-induced sexual dysfunction: high-level evidence is needed","volume":"67","author":"Berner","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD003546.pub3-BIB0125|cit125","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003546.pub2","article-title":"Management of sexual dysfunction due to antipsychotic drug therapy","author":"Berner","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003546.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T19:07:05Z","timestamp":1735499225000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003546.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,14]]},"references-count":125,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003546.pub3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717964701.793466485","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,14]]}}}